Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale.
Viana K, Zarpelon L, Leandro A, Terencio M, Lopes R, Martins C, Silva I, Sibim A, Marques F, da Silva R, Rivas A, Souza A, Dos-Santos A, Torres S, Garcia M, Giunchetti R, Chiba-de-Castro W.
Viana K, et al.
J Gen Virol. 2021 Nov;102(11):001684. doi: 10.1099/jgv.0.001684.
J Gen Virol. 2021.
PMID: 34788210
Free PMC article.